Published in Pharma Law Weekly, May 23rd, 2006
Current Technology Corporation reports Thomas R. Byrne, co-founder and Managing Director of Anchorage Capital Partners Limited (ACP), the company's corporate finance and investment advisor, has recommended focusing its European capital raising efforts on the venture capital trust (VCT) community in the United Kingdom.
"There are a number of compelling reasons for this focus on the tax-assisted VCT market," stated company CEO Robert Kramer. "Hundreds of millions of Pounds Sterling have been raised from investors by VCTs this year. Importantly, VCTs must hold...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Pharma Law Weekly